Spineway: nine-month sales up 40%.
The implant manufacturer, specializing in minimally invasive spine treatments, posted sales of 2.1 million euros for the quarter, down 8%.
But sales for the first nine months of the year came to 7.5 million euros, up 40% on last year.
The designer of surgical instruments explains that sales growth was mainly driven by the integration of Spine Innovations, a company consolidated since July 2022.
In Europe, sales jumped 101% to 3.6 million euros by the end of September, driven in particular by strong momentum in France (+67% to 2.1 million euros).
The share gained nearly 14% on the Paris Bourse after these figures, but continued to trade close to its all-time lows.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction